Browse Category

Investment News News 12 November 2025 - 13 November 2025

Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Vancouver / Jerusalem – November 13, 2025 – Shares of Clearmind Medicine Inc. (NASDAQ: CMND), a clinical‑stage psychedelic and neuroplastogen biotech company, jumped sharply on Thursday after the firm announced final approval to expand its FDA‑regulated Phase 1/2a clinical trial
Rivian (RIVN) Today: DA Davidson Lifts Price Target to $15 as CEO Pay Plan, AI Day and Q3 Momentum Dominate — Nov. 11, 2025

Rivian Stock Today, November 13, 2025: VW Mega‑Deal, CEO Pay Plan and Big Money Flows Shape RIVN Outlook

Rivian Automotive (NASDAQ: RIVN) is back in the headlines this Thursday as investors digest fresh news on its high‑stakes partnership with Volkswagen, a controversial multi‑billion‑dollar CEO pay package, and new disclosures showing big institutions both trimming and adding to positions.
1 115 116 117 118 119 131
Go toTop